angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with adenosine in 2 studies
Studies (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Trials (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Recent Studies (post-2010) (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
---|---|---|---|---|---|
311 | 5 | 64 | 32,536 | 1,075 | 8,930 |
Protein | Taxonomy | angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- (IC50) | adenosine (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Georgiev, V; Kambourova, T; Tchekalarova, J | 2 |
2 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and adenosine
Article | Year |
---|---|
Interaction between angiotensin IV and adenosine A(1) receptor related drugs in passive avoidance conditioning in rats.
Topics: 2-Chloroadenosine; Adenosine; Angiotensin II; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraventricular; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline | 2001 |
Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors.
Topics: Adenosine; Angiotensin II; Angiotensin III; Angiotensins; Animals; Brain; Convulsants; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Interactions; Epilepsy; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Seizures; Xanthines | 2001 |